Fortress Biotech FBIO Estimates

NASDAQ FBIO
$2.70 -0.03 (-0.92%)
As of: Sep 3, 2026 · 3:59 PM EDT
Analyst Estimates

Fortress Biotech, Inc. Revenue Estimates

Periods 19
Next Period Q2 26
Consensus 17.46 M

Analysts expect Fortress Biotech, Inc. to report revenue of 17.46 M for Q2 26, against a range of 16.32 M to 18.60 M. The most recent reported quarter, Q1 26, came in at 16.04 M, a 5.0% miss against the 16.89 M consensus.

Metric Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28
Reported (Actual) 14.90 M14.63 M15.12 M13.14 M16.41 M17.63 M16.08 M16.04 M--------
High Estimate 15.04 M32.62 M16.13 M12.95 M15.92 M22.93 M25.91 M17.91 M18.60 M24.99 M26.58 M28.46 M31.54 M33.46 M37.96 M32.11 M
Low Estimate 13.29 M29.56 M14.15 M11.41 M14.75 M21.02 M24.30 M15.87 M16.32 M22.58 M22.98 M24.14 M27.90 M29.45 M34.95 M26.72 M
Consensus Estimate 14.17 M31.09 M15.14 M12.18 M15.33 M21.97 M25.11 M16.89 M17.46 M23.79 M24.78 M26.30 M29.72 M31.45 M36.46 M29.41 M
Analyst Estimates

Fortress Biotech, Inc. Earnings Per Share (EPS) Estimates

Periods 19
Next Period Q2 26
Consensus -0.21

Analysts expect Fortress Biotech, Inc. to report earnings per share of -0.21 for Q2 26, against a range of -0.22 to -0.20. The most recent reported quarter, Q1 26, came in at 2.82 , in line with the -0.23 consensus.

Metric Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28
Reported (Actual) -0.73-0.76-0.17-0.480.450.11-0.152.82--------
High Estimate -1.10-0.59-0.67-0.47-0.32-0.380.13-0.21-0.20-0.13-0.141.90-0.35-0.81-1.023.53
Low Estimate -1.18-0.65-0.77-0.55-0.38-0.420.11-0.25-0.22-0.15-0.161.76-0.39-0.91-1.103.15
Consensus Estimate -1.14-0.62-0.72-0.51-0.35-0.400.12-0.23-0.21-0.14-0.151.83-0.37-0.86-1.063.34